Objectives-To obtain summary measures of the relation between cumulative exposure to asbestos and relative risk of lung cancer from published studies of exposed cohorts, and to explore the sources of heterogeneity in the doseresponse coefficient with data available in these publications. cohorts in which the doseresponse relation between cumulative exposure to asbestos and relative risk of lung cancer has been reported were identified. Linear dose-response models were applied, with intercepts either specific to the cohort or constrained by a random effects model; and with slopes specific to the cohort, constrained to be identical between cohorts (fixed effect), or constrained by a random effects model. A meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer Cumulative exposure strata were usually defined by a range, often with an open end for the highest exposure stratum-for example, > 100 fibre-year/mnl (f-y/ml). We assigned fixed exposures to these ranges as the midpoint of the range, unless a mean or median was reported. For open ended categories, we assigned a fixed exposure by repeating the pattern found at lower exposures. We calculated 95% confidence intervals (95% CIs) about the SMR for each cumulative exposure with an approximation to a Poisson distribution. For each study reporting SMRs for more than one cumulative exposure category, we fitted the following dose-response model:
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Under this model, potency, k,, is fourfold lower than that calculated by the United States Occupational Safety and Health Administration. Occupational exposure to asbestiform fibres causes lung cancer. ' The relation between extent of exposure and risk of lung cancer influences (a) regulatory activity,2 (b) estimates of risk from low level exposures to asbestos,3 and (c) prediction of the impact of exposures on public health-such as lung cancer mortality among exposed workers in asbestos industries.4 Overviews of the doseresponse relation conducted to date have been semiquantitative and have not been examined in the light of updates of the cohort studies upon which they rely. We present a quantitative meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer. We discuss potential sources of heterogeneity in the relation that was evident in the studies.
Methods
We identified published studies by reviewing an existing overview of the dose-response relation,' searching the Medline database from 1966 to December 1995, and by searching citations in the studies found by the first two methods. Any study reporting a measure of the relative risk for lung cancer associated with a quantitative measure of cumulative exposure was eligible for the meta-analysis. No such studies were intentionally excluded. Most studies identified, and all studies included in the meta-analysis, were retrospective cohort studies of mortality due to lung cancer. The diseases encompassed by the term lung cancer differed in the different studies. We abstracted and report, when available, the international classification of diseases (ICD) codes included under the definition of lung cancer in each study. We also extracted from each study the cohort entrance requirements; number, sex, and race of people studied; amount of person-time accumulated, noting exclusions; type of asbestos industry and of asbestos fibre; method of estimating cumulative exposure; characteristics of the referent population; method of ascertaining vital status and of classifying causes of death; number of total lung cancer deaths observed; number of observed and expected lung cancer deaths, and the corresponding standardised mortality ratio (SMR), within cumulative exposure strata; and any information on tobacco use by the cohort.
Cumulative exposure strata were usually defined by a range, often with an open end for the highest exposure stratum-for example, > 100 fibre-year/mnl (f-y/ml). We assigned fixed exposures to these ranges as the midpoint of the range, unless a mean or median was reported. For open ended categories, we assigned a fixed exposure by repeating the pattern found at lower exposures. We calculated 95% confidence intervals (95% CIs) about the SMR for each cumulative exposure with an approximation to a Poisson distribution. For each study reporting SMRs for more than one cumulative exposure category, we fitted the following dose-response model: Ej = Ai ( of its rank. Figure 1 justifies the use of a log normal distribution for k, in the random effects model. Figure 2 shows that a log normal distribution is appropriate for the A, in the random effects model, as does the log normal distribution of SMRs for lung cancer found in 88 unexposed cohorts. 30 We considered using these unexposed cohorts to provide a prior estimate of the distribution of the Ai, but discovered that the distribution obtained from the asbestos cohorts differed significantly (P = 0-002).
Under the fixed effect model, from the 15 cohorts, we obtained a maximum likelihood estimate of k, equal to 0-42 x 10-3 (95% CI 0-22 to 0-69 x 10-3) ml/f-y. Under the random effects model, implemented because we found substantial heterogeneity in the estimates of ki, and Ai, we found a maximum likelihood estimate of a, equal to 2-6 x 10-3 (95% CI 0.65 to 7.4 x 10-3 ) ml/f-y and a maximum likelihood estimate of A equal to 1X36 (95% CI 1.05 to 176). Our estimates of k,,i ranged from 0 ml/f-y"l 13 20 to 42 x 10-3 ml/ f&y. '6 The dose-response model could not be fitted to two of the studies12 25 because only one cumulative exposure category was reported.
Given the substantial range of the k1,i, we thought it imperative to measure possible causes for the heterogeneity found. TOBACCO 
HABITS
The prevalence of tobacco use among asbestos workers in different cohorts, compared with their standard populations, provides a likely source of heterogeneity in the dose-response coefficient. To evaluate this source, we allowed the intercept of the dose-response curve to differ from 1I0. We then fitted a model that forced the effect of asbestos exposure to multiply the intercept. Positive interaction between occupational exposure to asbestos and tobacco use would cause higher values for k1,i to be found in studies in which the deviation between tobacco use in the cohort and the standard population is greatest. This required an assumption that the deviation of the intercept from 1-0 was constant across all dose groups. None the less, we expected some residual heterogeneity due to variation in relative tobacco habits. This expectation arose because cumulative tobacco use probably correlates with cumulative 2a tFinkelstein (1984) ."0 535 men employed for at least one year between 1948 and 1 January 1960 at an asbestos cement building materials plant in Ontario, Canada that used chrysotile, crocidolite, and silica. 26 lung cancer deaths, ascertained by coding of death certificates obtained after checking vital status in local and national records, were observed in 6328 person-years of follow up accumulated to 31 December 1977. Expected lung cancer rates (ICD-8 162) estimated from age and sex specific Ontario rates, 1970 to 1974, with only person-time more than 20 years after the onset of exposure contributing. Cumulative exposure based on personal and ambient workplace air measurements beginning in 1949 and work histories up to 18 years. Exposures longer than 18 years generally contributed less than 10% of the total. Person-years were contributed to the cumulative exposure category attained 10 years previously. 16 of 17 lung cancer cases queried were current or ex-smokers. k, = 6-9 x 10-3 (95% CI = 0 to 250 x 10-3) ml/f y.
Value used in Range in study meta-analysis (f-y/ml) (f-ylml) mlJf-y; and Aheavy smokers = 2 11 and kl,heavy smokers = 0X8 x 10-ml/f-y. A test of the hypothesis of uniform k, yielded P = 0 12 and a uniform estimate of k, in all smoker groups of 0-8 x 10 -3ml/f-y. Given the small number of lung cancers found among non-smokers, the test for homogeneity should not be considered particularly powerful. Pooling the observed and expected lung cancers across smoker strata within dose groups, and then implementing the dose-response model-that is, reaggregating the data into the form that they are usually reported-yielded Apooled= 0-96 and pooled = 0-9 x 10-3 ml/f-y. Analyses of the first study of the cohort28 yielded similar results. These data provide weak evidence that the dose-response coefficient is larger among non-smokers than among smokers and that the opposite is true for the intercept term.
The pooled estimates of kli and Ai may depend, therefore, on the tobacco habits of the cohorts. The variability of tobacco habits in the cohorts included in the meta-analysis, compared with their respective standard populations, should be considered to be a source of heterogeneity. Under the fixed effect model, we found that these industry categories were a significant source of heterogeneity (P < 0 001). The fixed effect dose-response coefficient for the mining and milling cohorts was k,mm = 0-3 x 10-3 (95% CI 0-01 to 0-5 x 10 -3) ml/f-y, for the cement products cohorts it was k',cem = 3.4 x 10-3 (95% CIO 1 to 8-8 x 10-3) ml/fy, and for the manufacturing and textile cohorts it was Ki,ma, = 7.7 x 10-3 (95% CI 4-7 to 12 x 10-3) ml/f-y. Addition of a variable representing a uniform multiplicative modification to the industry specific doseresponse coefficients for cohorts exposed to predominantly chrysotile fibres added no significant information (P = 0-58), suggesting that after accounting for industry type, fibre type added no significant heterogeneity. Ignoring the industry specificity, the uniform multiplicative modification to the overall k, under the fixed effect model for cohorts exposed to predominantly chrysotile fibre equaled 0-05 (95% CI 0-02 to 0-14) with kj = 5.4 x 10-3(95%CI2-5toll x 10 -3)ml/f-y.
Under the random effects model, applied to each of the three subsets of cohorts, we found insufficient evidence that industry category was a significant source of heterogeneity (P = 0-58). The maximum likelihood estimates of the industry specific dose-response coefficients under the random effects model were similar to those estimated under the fixed effect model. The uniform multiplicative modification to the overall ki under the random effects model for cohorts exposed to predominantly chrysotile fibre equaled [0] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] (95% CI 0-02 to 1-6) with K, = 7.9 x 10-3 (95% CI 1.2 to 43 x 10-3) ml/f-y. Fibre type, even independent of industry type, did not contribute significantly to the heterogeneity under the random effects model.
The disparity in the strength of the evidence supporting the hypothesis of industry specific dose-response coefficients under the fixed and random effects models probably arises from the treatment of the intercept terms. Under the fixed effect model, the Ai are fitted to their maximum likelihood value conditional on the dose-response coefficient, whether it be the summary or industry specific measure. The strength of the evidence supporting industry specific dose-response coefficients under the fixed effect model reflects both the goodness of fit of the dose-response and the additional freedom of fitting the intercept terms conditional on three, rather than 9 tMcDonald et al (1984 (Nicholson, 1983 (1-49 to [14] [15] [16] [17] [18] [19] [20] [21] [22] one, dose-response coefficients. Under the random effects model, the Ai are assumed to derive from a distribution of intercepts. We allowed the distribution to be fitted to each industry, thus providing the greatest power to detect differences in dose-response. None the less, constraining the intercept term to an industry specific distribution significantly reduced the strength of the evidence supporting the notion of industry specific doseresponse coefficients. We conclude that industry type is a source of heterogeneity in these cohorts, but that the importance of its contribution to the heterogeneity of the doseresponse coefficients is overstated under the fixed effect model.
DOSE MEASURE
Equivalent dose measures assigned to cumulative exposure categories in different cohorts likely reflect vastly different actual cumulative doses. We expect that differences in methods of measuring fibre concentrations and assigning cumulative exposures across studies introduce an important source of heterogeneity in dose-response coefficients. We explain with three lines of evidence. Firstly, for most cumulative exposure categories we assigned the midpoint of the range as the dose to be used in the dose-response analysis. For four cohorts'9 917 we used the mean cumulative exposure because it had been provided for each cumulative exposure category. Reanalysing these studies based on the midpoints rather than the means, we obtained ratios of kIimean/kIimidpoint of 1 0, 06, 07, and 1-5, respectively. Thus, substituting the midpoint for the mean, as we were forced to do for most cohorts, can artificially inflate or deflate the dose-response coefficient and must contribute to its heterogeneity. Secondly, some studies reported cumulative exposure categories in units other than f-y/ml. For those studies, we converted from the stated units to f-y/ml with the following conversion factors: fy/ml = 1-4 x mppcf-y (million particles per cubic foot-year) for the cement and manufacturing industries5; f-y/ml = 3 x mppcf-y for the mining and milling industries5; and f-y/ml = 1/35 x py/ml (particles per millilitre-year) for the textile industry.'7 We parameterised these three conversion factors and maximised the likelihood under the fixed effect model with respect to K,, Ai, and the conversion parameters. We obtained estimates of the conversion factors equal to f-y/ml = 0-6 x mppcf-y for the cement and manufacturing industry; fy/ml = 0-07 x mppcf-y for the mining and milling industry; and f-y/ml = ppcf-y/80 for the textile industry. We cannot distinguish the extent to which the disparity between the published conversion factors and these maximum likelihood estimates depend on industry specific differences in fibre potency versus heterogeneity in estimating cumulative exposures between studies. We suspect that both factors play some part. Thirdly, we noted above a significant correlation between k,,i and the maximum cumulative exposure studied. This correlation provides the strongest evi- 
DURATION VERSUS CONCENTRATION OF EXPOSURE
We considered the possibility that short exposure to high concentrations might confer different relative risk of lung cancer than long exposure to low concentrations, although both would entail similar cumulative exposures. Were this the case, then different patterns of exposure in different cohorts would contribute to heterogeneity. To test the hypothesis, we fitted the fixed effect model to the mean duration of exposure and mean concentration of exposure data provided in one study28 and to the midpoint exposure and midpoint concentration data provided in a second. 8 We added to the relative risk model coefficients applied only to the concentration term and only to the duration term, while retaining the coefficient (kl) applied to the product of the two. For both studies, the additional coefficients added no significant information to the relative risk model (P = 0.4228 and P = 0438). We conclude that, within the cumulative dose ranges found in the studies at issue, the product of concentration and duration of exposure adequately measured dose. Thus, variation in patterns of exposure within cohorts is unlikely to be an important source of heterogeneity in the dose-response coefficient. (0-65 to (0-52 to 1-06)
We discerned no patterns in any of these plots,
(1 00 to 1387) so consider the calendar period of exposure to
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be a negligible source of heterogeneity. An earlier, semiquantitative review by Nicholson for OSHA5 of the relation between cumulative exposure to asbestos and relative risk of lung cancer gave a potency of ki = 10 X 10-3 (range 3-30 x 10-3) ml/f-y. The central tendency was selected as approximately the geometric mean of the individual k,j, and the range about the estimate derived primarily from consideration of uncertainties in the dose-measurements. The OSHA2 adopted this estimate of a, in their 1986 rules. Our estimates for potency, kl, are 24-fold lower than OSHA's under the fixed effect model and fourfold lower under the random effects model. Further, our 95% CIs exclude 10 x 10-3 ml/f-y under both models. Our study differs from the earlier review in the following respects. Firstly, we had available updates to many cohorts with additional cohort information that had not then been published. As shown above, updates have consistently yielded a lower estimate of kjj. Secondly, we allowed the intercept term to depart from a fixed value of 1-0 to allow for confounding, most likely by smoking, or the healthy worker effects. The earlier review, when calculating k,,i by regression methods, fixed the intercept at 1. Thirdly, we effectively weighted each measurement of relative risk within a cohort by the number of cases of lung cancer. The earlier review usually weighted all measurements of relative risk within a cohort equally. Fourthly, we weighted each study by the number of cases of lung cancer in the study to obtain our summary measures of effect. The earlier review, by choosing the approximate geometric mean, weighted each study uniformly. Fifthly, we calculated a summary measure under both a fixed effect model and a random effects model. The earlier review, by virtue of choosing the geometric mean of the individual study k,,i, is more analogous to a random effects model.
The issue of publication bias must, by convention, be considered. We do not deny the possibility that unpublished studies, or published studies unknown to us, exist that may alter these findings, possibly toward the null. Given the well accepted role of occupational exposure to asbestos in causing lung cancer, we find it unlikely that the 95% CI about our summary measures would overlap the null if these absent studies were to be included. Publication bias of this sort in meta-analyses is analogous to the problem of unknown confounders in aetiological research. The role of unknown confounders in aetiological research or of publication bias in meta-analyses can never be rulled out. The extent to which a given aetiological association is confounded by unknown causes, or to which a given metaanalytical result is influenced by publication bias, is a matter of individual judgment; it cannot be subjected to the scientific method.
A second sort of publication bias is of more concern to this meta-analysis. It may be that only cohorts that, in aggregate, show a positive relation between asbestos exposure and relative risk of lung cancer are subjected to further analysis and expenditure of resources by disaggregation into cumulative exposure categories. Such a practice would bias the results of this meta-analysis away from the null. It may also be that investigators, upon obtaining a null result, would choose to disaggregate the cohort into cumulative exposure categories in the hopes of finding effects in the highest exposure groups or a positive dose-response trend. Apparent examples of both possibilities exist in the publications upon which we based our report. We cannot assess the extent to which the two possibilities balance within the larger body of scientific literature. 
